How has been the historical performance of Niva Bupa Health?

Answer:The historical performance of Niva Bupa Health shows significant growth in its financial metrics over the past year.

Breakdown:
In the fiscal year ending March 2025, Niva Bupa Health reported net sales of 4,894.46 Cr, an increase from 3,811.25 Cr in March 2024. The total operating income also rose to 5,374.28 Cr from 4,115.47 Cr in the previous year. Total expenditure, excluding depreciation, increased to 5,316.18 Cr from 4,254.40 Cr, primarily driven by higher manufacturing expenses which grew to 4,061.10 Cr from 3,000.37 Cr. Despite the rise in expenses, the company achieved an operating profit (PBDIT) of 213.52 Cr, up from 81.85 Cr, indicating a strong recovery as the operating profit margin improved to 1.19% from a negative margin of -3.65%. The profit after tax also saw a substantial increase to 213.52 Cr from 81.85 Cr, resulting in an earnings per share (EPS) of 1.17 compared to 0.48 in the prior year. On the balance sheet, total assets grew to 6,191.87 Cr from 3,876.57 Cr, with total reserves increasing significantly to 1,231.29 Cr from 350.24 Cr. Cash flow from operating activities rose to 812.00 Cr from 592.00 Cr, while cash and cash equivalents at the end of March 2024 stood at 142.00 Cr, up from 101.00 Cr the previous year. Overall, Niva Bupa Health demonstrated robust growth across various financial metrics, reflecting a positive trend in its operational performance.